Article Details

Caladrius Biosciences (NASDAQ:CLBS) Earns Sell Rating from Analysts at StockNews.com

Retrieved on: 2022-05-22 17:11:45

Tags for this article:

Click the tags to see associated articles and topics

Caladrius Biosciences (NASDAQ:CLBS) Earns Sell Rating from Analysts at StockNews.com. View article details on hiswai:

Excerpt

The biotechnology company reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates of ($0.10) by $0.03. During the ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up